secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2025-08-25T23:59:59+00:00
Accession:  0001193125-25-187680
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Douglas Barry resigns as Chief Legal Officer and Corporate Secretary of Tango Therapeutics
--------------------------------------------------------------------------------

- Douglas Barry resigned as Chief Legal and Compliance Officer and Corporate Secretary effective September 12, 2025.
- No replacement named; Barry departing to pursue another opportunity.
- Resignation covers both officer and corporate secretary roles simultaneously.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312525187680/0001193125-25-187680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312525187680/d88761d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-187680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer